News | News By Subject | News by Disease News By Date | Search News

Biotechnology News Articles on Industry Topics

Get Our FREE
Industry eNewsletter
Top Breaking News
BioMarin Pharmaceutical Inc. (BMRN) Sells Priority Review Voucher For $67.5 Million     7/31/2014
SoCal Biopharma Cold Genesys, Inc. Locks In $13.57 Million Series A     7/31/2014
Amgen (AMGN) Eliminating Up To 2,900 Jobs; Will Shutter Seattle, Bothell Sites     7/30/2014
Amid Cuts, Amgen (AMGN) To Add Jobs In Cambridge, Massachusetts     7/30/2014
Rumor: Sarepta Therapeutics (SRPT) Chairman Moves To Keep CEO Out Of FDA Meetings     7/30/2014
AstraZeneca PLC (AZN) Scoops Up Almirall Lung Drugs For Up To $2.1 Billion     7/30/2014
Pfizer Inc. (PFE) Grabs Baxter International, Inc. (BAX)'s Portfolio Of Marketed Vaccines For $635 Million     7/30/2014
Regeneron Pharmaceuticals, Inc. (REGN), Sanofi (France) (SAN.PA) Drug Alirocumab Cuts Cholesterol In Nine Late-Stage Trials     7/30/2014
Incyte Corporation (INCY) Partners With Genentech (RHHBY) To Help With Cancer Immunotherapy Trials     7/30/2014
IMPAX Laboratories, Inc. (IPXL) Parkinson's Drug Future Shaky As FDA Cites Factory Issues     7/30/2014
Pfizer Inc. (PFE) CEO Aggressively Seeking Deals, Leaves Investors Guessing On AstraZeneca PLC (AZN) Intentions     7/30/2014
Merck & Co., Inc. (MRK): No Tax Inversions, We Just Want Bolt-On Deals     7/30/2014
Leidos Awarded $44 Million Contract By The Centers for Disease Control and Prevention (CDC)     7/30/2014
TherapeuticsMD, Inc.  (TXMD) Announces $40 Million Offering Of Common Stock     7/30/2014
Second Failure Of The Month As Targacept, Inc. (TRGT) Halts Development Of Bladder Drug, Shares Plunge     7/29/2014

Featured Stories
Psychologists Discover A Surprising Thing Happens To Kids Who Read Harry Potter, University of Modena Reveals     7/31/2014
Three Things To Take Away From Amgen (AMGN)'s Big Restructuring     7/30/2014
Could The Ebola Virus Become A Threat In The U.S.?     7/30/2014
BioPharm Executive: Have Drugs Finally Been Priced Too High?     7/30/2014
No Extra Benefit Found In Eating More Than Five Portions Of Fruit And Veggies A Day, British Medical Journal Reveals     7/30/2014
Facial Features Are The Key To First Impressions, University of York Study     7/30/2014
Wide-Faced Men Negotiate Nearly $2,200 Larger Signing Bonus, University of California, Riverside Study     7/30/2014
Drinking In Midlife Doubles Chance Of Memory Problems In Later Life, University of Exeter Study     7/30/2014
Do Drug Companies Make Drugs Or Money?     7/30/2014
Allergan Inc. (AGN) Layoffs: Employees Tell Their Side Of The Story     7/29/2014
Want To Live Longer? Go For A Five Minute Run, Says Iowa State University Researcher     7/29/2014
OKCupid Admits: "We Experiment On Human Beings!"     7/29/2014
Why Men Like Nice Women And Why Women Like Bad Boys, University of Rochester Study     7/29/2014
Novartis AG (NVS) Layoffs: Game-Changing Tips For Today’s Job Seeker     7/29/2014
Mom's Fears Are Passed Down To Their Kids Through Smell, University of Michigan Medical School Research Finds     7/29/2014

More News
Perrigo Company (PRGO) Confirms First To File Patent Challenge For Generic Version Of Topicort® Topical Spray 0.25%     7/30/2014
Orexigen Therapeutics, Inc. (OREX) Receives CHMP Day 180 List Of Outstanding Issues     7/30/2014
Eisai Inc. (ESALF.PK) And Arena Pharmaceuticals, Inc. (ARNA) Announce Publication Of Post-Hoc Analyses Of Lorcaserin Phase 3 Clinical Trial Results In Obesity     7/30/2014
Alkermes plc (ALKS) Announces Initiation Of FORWARD-5 Clinical Study Of ALKS 5461 For Treatment Of Major Depressive Disorder     7/30/2014
Immune Pharmaceuticals, Inc. Commences Patient Screening For Bertilimumab Phase II Clinical Trial In Bullous Pemphigoid, A Rare Auto-Immune Disease Of The Skin     7/30/2014
Amarantus BioSciences, Inc. Amends LymPro LP-002 Clinical Protocol to Report Interim Data at Presentation     7/30/2014
BioTie Therapies Corp. Updates Outlook On Tozadenant And SYN120     7/30/2014
AtheroNova Inc. (AHRO.OB) Announces Milestone With Initiation Of Phase 1b Clinical Trial Of AHRO-001     7/30/2014
Galectin Therapeutics Issues Statement on GR-MD-02 Development Program     7/30/2014
Fate Therapeutics (FATE) Announces FDA Clearance Of IND For Clinical Development Of PROHEMA In Inherited Metabolic Disorders     7/30/2014
Syndax Pharmaceuticals Inc. Release: Entinostat Improves Treatment Outcomes When Combined With Immune Checkpoint Blockade In Preclinical Tumor Models     7/30/2014
FDA Release: EYLEA® (aflibercept) Injection Receives FDA Approval For The Treatment Of Diabetic Macular Edema (DME)     7/30/2014
The Crohn's & Colitis Foundation Of America Release: Focusing On Bacteria's Role In Inflammatory Bowel Disease     7/30/2014
CSL Behring Release: Study Suggests C1-INH May Aid In Prevention Of Antibody-Mediated Rejection Following Kidney Transplant     7/30/2014
Tigermed And Frontage Laboratories Complete Strategic Investment Agreement     7/30/2014
Kaiser Permanente, Johns Hopkins Medicine Announce Enhanced Strategic Collaboration     7/30/2014
Evotec AG (EVTG.F) Receives First Milestones In TargetAD Collaboration     7/30/2014
Theraclone Sciences, Inc. Announces Exclusive Agreement With Gilead Sciences, Inc. (GILD) For Broadly Neutralizing HIV Antibodies     7/30/2014
Massachusetts Biotechnology Council, Inc. Announces New Collaboration With Life Sciences Market Intelligence Firm Evaluate Ltd.     7/30/2014
Baylor Sammons Cancer Center Joins As Clinical Trial Site For Actinium Pharmaceuticals, Inc. (ATNM.OB)’s Actimab-A Clinical Trial     7/30/2014
Lion Biotechnologies, Inc. Enters Clinical Trial Grant Agreement With H. Lee Moffitt Cancer Center & Research Institute     7/30/2014
Durata Therapeutics, Inc.  (DRTX) Enters Into An Exclusive License And Supply Agreement With Angelini To Commercialize Dalbavancin In Certain European Territories, Russia And Turkey     7/30/2014
Anika Therapeutics (ANIK) Announces U.S. Commercialization Partnership For Hyalomatrix® With Wound Care Leader Medline Industries, Inc.     7/30/2014
Florida Institute Funds Miami-based RxMP Therapeutics, LLC     7/30/2014
Proteostasis Therapeutics, Inc. Announces Achievement Of Preclinical Milestone In Neurodegenerative Diseases Collaboration With Biogen Idec, Inc. (Massachusetts) (BIIB)     7/30/2014
PCI Announces Definitive Agreement To Acquire Penn Pharma     7/30/2014
National Institutes of Health (NIH) Awards Imbed Bio A $1.5M Grant To Develop Advanced Wound Healing Nanofilm     7/30/2014
Chromatin, Inc. And California Ethanol Producers To Support Sorghum Feedstock Program With California Energy Commission’s $9 Million Grant     7/30/2014
North Carolina Biotechnology Center Awards $1.5 Million In Quarter, Loan Recipients Net $77 Million     7/30/2014
GlaxoSmithKline (GSK)'s Tanzeum™ Is Now Available In Pharmacies In The U.S.     7/30/2014
INNOPHARMA Announces Launch Of Olanzapine For Injection, 10mg/Vial In Canada     7/30/2014
GenSpera Announces US Patent For Methods And Compositions For The Detection, Imaging And Treatment Of Cancer     7/30/2014
Lightlake Therapeutics Inc. (LLTP) Receives Funding Commitment From A Prominent International Research And Development Foundation     7/30/2014
Axxess Pharma, Inc. Secures $2 Million USD In Financing To Fulfill Increased Rate Of Purchase Orders     7/30/2014
Sequenom Inc. (SQNM) Announces Closing Of Initial Public Offering     7/30/2014
Intersect ENT Announces Closing Of Its Initial Public Offering     7/30/2014
Innophos Holdings, Inc. Declares Dividend Of $0.48 Per Share; Increases Rate By 20%     7/30/2014
Gevo, Inc. Announces Proposed Public Offering Of Common Stock And Warrants     7/30/2014
Hantian Labs Ltd. Introduces Trailblazing Anti-Aging And Vitality Product For Men, GHBurn     7/30/2014
ContraFect Corporation (CFRXU) To Ring The NASDAQ Stock Market Opening Bell     7/30/2014
Immune Design Corporation (IMDZ) Announces Closing Of Initial Public Offering     7/30/2014
RXi Pharmaceuticals (RXII) Expands Clinical Program With Initiation Of Third Phase 2a Study With RXI-109 For Treatment Of Hypertrophic Scars     7/30/2014
Gilead Sciences, Inc. (GILD) Allows China/Indian Pharmas To Make Generic Version Of Novel HIV Drug     7/30/2014
Change In The Number Of Votes Relating To BioTie Therapies Corp.'s Shares     7/30/2014
Kraig Biocraft Laboratories, Inc. Implements Innovative Protocol For Advanced Fiber Quality Control     7/30/2014
Harlan Provides Expertise For Biologics And Biosimilars     7/30/2014
Software Updates Simplify Protein Analysis For Avacta’s Optim® Instruments     7/30/2014
TherapeuticsMD, Inc.  (TXMD) Announces Pricing Of Offering Of Common Stock     7/30/2014
Tauriga Sciences Inc. (TAUG) Approved To Continue Trading On OTCQB Marketplace     7/30/2014
Welcome To The Annual General Meeting Of Shareholders Of Elekta AB (SE:EKTAB) (Publ)     7/30/2014
Radius (RDUS) To Ring The NASDAQ Stock Market Closing Bell     7/30/2014
Ampio Pharmaceuticals, Inc. (AMPE) Announces The FDA Has Issued A Written Response And Accepted The Ampio Plan For Beginning Production Of Ampion™ In The New Facility     7/30/2014
EDG Partners Invests In MMIS     7/30/2014
Intouch Solutions Launches SocialQueue™, A Real-Time Social Monitoring Tool For Pharma     7/30/2014
Ready-to-Use EZ-Fit™ Filtration Unit From EMD Millipore Leverages Industry Leading Technology For More Efficient Bioburden Testing Of Liquids     7/30/2014
Bio-Rad Laboratories, Inc. (BIO) Introduces SureBeads™ Magnetic Bead Immunoprecipitation System     7/30/2014
W. R. Grace & Company Launches New REVELERIS® Prep Purification System     7/30/2014
Aegerion Pharmaceuticals, Inc. (AEGR) Announces Second-Quarter 2014 Financial Results     7/30/2014
Almirall's H1 Results 2014: Continued Growth Acceleration     7/30/2014
BioLineRx Ltd. To Report Second Quarter 2014 Results On August 6, 2014     7/30/2014
BioTie Therapies Corp. Interim Report 1 January - 30 June 2014     7/30/2014
BioMarin Pharmaceutical Inc. (BMRN) Announces Second Quarter 2014 Financial Results     7/30/2014
Cempra, Inc. Reports Second Quarter 2014 Financial And Operating Results     7/30/2014
Cambrex Corporation (CBM) To Announce Second Quarter 2014 Financial Results On August 1, 2014     7/30/2014
Covance Inc. (CVD) Reports Second Quarter Net Revenue Growth Of 8.0% To $639 Million, Pro Forma EPS Growth Of 21.5% To $0.95 And Adjusted Net Orders Of $773 Million     7/30/2014
Covance Inc. (CVD) Invites You To Join The Webcast Of Its Second Quarter 2014 Financial Results Conference Call     7/30/2014
Celladon Corporation To Report Second Quarter 2014 Results On August 7, 2014     7/30/2014
Discovery Laboratories (DSCO) To Report 2014 Second Quarter Financial Results And Hold Conference Call On Tuesday, August 5, 2014 At 9:00 A.M. Eastern Time     7/30/2014
Dyax Corp. (DYAX) Announces Second Quarter 2014 Financial Results     7/30/2014
Dr. Reddy's Laboratories Ltd. (RDY)’s Q1 FY15 Financial Results     7/30/2014
Endocyte, Inc. (ECYT) Reports Second Quarter Financial Results And Provides Clinical Update     7/30/2014
Evoke Pharma, Inc. Schedules Webcast And Conference Call For Second Quarter 2014 Financial Results     7/30/2014
Eagle Pharmaceuticals (EGRX) Schedules Third Quarter Earnings Release And Conference Call     7/30/2014
Evogene Ltd. (EVGN)’s Second Quarter 2014 Earnings Announcement Schedule     7/30/2014
Five Prime Therapeutics, Inc. (FPRX) To Announce Second Quarter Financial Results And Host Conference Call On August 5, 2014     7/30/2014
Guerbet (GBT): 2014 First-Half Results     7/30/2014
GW Pharmaceuticals To Report Q3 2014 Financial Results And Host Conference Call On 6 August, 2014     7/30/2014
Geron Corporation (GERN) Announces Conference Call To Discuss Second Quarter 2014 Financial Results     7/30/2014
Genocea Biosciences To Announce Second Quarter 2014 Financial Results On August 6, 2014     7/30/2014
Hospira, Inc. Reports Second-Quarter 2014 Results     7/30/2014
Horizon Pharma To Host Conference Call And Webcast To Discuss Second Quarter 2014 Financial Results On August 7, 2014     7/30/2014
ImmunoCellular Therapeutics, Ltd (IMUC) To Report Financial Results For The Second Quarter 2014 On August 7, 2014     7/30/2014
IMRIS To Hold Second Quarter 2014 Results Conference Call     7/30/2014
ICON Reports Second Quarter 2014 And Increases Earnings Guidance     7/30/2014
INSYS Therapeutics To Report Second Quarter 2014 Results     7/30/2014
Landauer (LDR) Sets Date And Time For Announcement Of Fiscal Third Quarter 2014 Results     7/30/2014
MacroGenics, Inc. (MGNX) Announces Date Of Second Quarter 2014 Financial Results Conference Call     7/30/2014
Neurocrine Biosciences, Inc. (NBIX) Announces Conference Call And Webcast To Report Second Quarter 2014 Financial Results     7/30/2014
Novavax, Inc. (NVAX) To Host Conference Call To Discuss Second Quarter 2014 Financial Results On August 6, 2014     7/30/2014
Portola Pharmaceuticals, Inc. To Announce Second Quarter 2014 Financial Results And Host Conference Call On Wednesday, August 6, 2014     7/30/2014
Pain Therapeutics (PTIE) To Host Conference Call To Discuss Q2 2014 Financial Results     7/30/2014
QIAGEN N.V. (QGEN) Reports Second Quarter And First Half 2014 Results And Announces Launch Of New $100 Million Share Repurchase Program     7/30/2014
ReVance Therapeutics, Inc. (RVNC) To Release Second Quarter 2014 Financial Results And Host Conference Call On Tuesday, August 12, 2014     7/30/2014
Regado Biosciences, Inc. (RGDO) To Provide Second Quarter 2014 Financial Results And Corporate Highlights     7/30/2014
Synta Pharmaceuticals (SNTA) To Host Conference Call And Webcast Of Second Quarter 2014 Financial Results On August 6, 2014     7/30/2014
Sorin Group S.p.A. (SRN) Announces Results For The Second Quarter Of 2014     7/30/2014
Targacept, Inc. (TRGT) To Report Second Quarter 2014 Financial Results On August 6, 2014     7/30/2014
Vertex Pharmaceuticals Incorporated (VRTX) Reports Second Quarter 2014 Financial Results And Provides Updates On Key Research And Development Programs     7/30/2014
XOMA (US) LLC (XOMA) To Announce Second Quarter 2014 Financial Results And Host Webcast On August 7     7/30/2014
Franz Och, Ph.D., Expert in Machine Learning and Machine Translation, Joins Human Longevity, Inc. as Chief Data Scientist     7/30/2014
Thomas Dubinski Joins Dyadic International, Inc. As Chief Financial Officer     7/30/2014
Aegerion Pharmaceuticals, Inc. (AEGR) Appoints Craig Fraser As Chief Operating Officer     7/30/2014
MYOS (MYOS) Announces Appointment Of Douglas Weekes As Chief Commercial Officer     7/30/2014
Celldex Therapeutics, Inc. (CLDX) Announces Senior Leadership Promotions     7/30/2014
Rafarma Pharmaceuticals Announces New President As Part Of Pending Acquisition Of Majority Interest     7/30/2014
Marathon Pharmaceuticals Names Jeanine Swalec Vice President Of Regulatory Affairs     7/30/2014
Aceto Corporation Appoints Daniel Yarosh, Ph.D. To The Board Of Directors     7/30/2014
Epic Sciences Appoints Greg Lucier As Chairman Of The Board Of Directors     7/30/2014
Envisia Therapeutics Announces Appointments To Board Of Directors     7/30/2014
GRAMMY® Award-Winning Singer Jennifer Hudson Lends Her Voice To Stand Up To Cancer And Genentech (RHHBY) In "Two Worlds. One Dream." Campaign In The Fight Against Cancer     7/30/2014
California Healthcare Institute (CHI) Releases Report Highlighting Public Impact Of Hepatitis C, Opportunities For Action In U.S.     7/30/2014
Access Pharmaceuticals (ACCP) Featured On     7/30/2014
BG Medical Technologies To Give Free Medical Marijuana Educational Materials To Physicians     7/30/2014
Janssen Pharmaceutical Inc. Announced As NASCAR Sprint Cup Series™ Event Entitlement Partner At Chicagoland Speedway     7/30/2014
TransCelerate BioPharma, Eli Lilly and Company (LLY), Pfizer Inc. (PFE), And FDA Highlight Collaborative Program At The Site Solutions Summit     7/30/2014
Alexza Pharmaceuticals, Inc. (ALXA) Announces Participation In Upcoming Investor Conferences     7/30/2014
PDL BioPharma, Inc. (PDLI) To Participate In Jefferies and Co. 2014 Boston Healthcare Summit     7/30/2014
Omega Protein Corporation (OME) To Present At The Canaccord Genuity 34th Annual Growth Conference     7/30/2014
The 2014 BioFlorida Life Sciences Annual Conference     7/30/2014
Egalet To Present At The Canaccord Genuity Growth Conference On August 13     7/30/2014
BIND Therapeutics (BIND) To Present At Wedbush 2014 Life Sciences Management Access Conference     7/30/2014
PTC Therapeutics, Inc. (PTCT) To Present At The Wedbush Life Sciences Management Access Conference     7/30/2014
BioSpace (DHX) Map Features Midwest Biotech Leaders     7/30/2014

Career Tips
Novartis AG (NVS) Layoffs: Game-Changing Tips For Today’s Job Seeker     7/29/2014
Half Of Biotech Employees Dissatisfied With Their Employer     7/24/2014
5 Overused Phrases To Avoid Putting On Your Resume     7/24/2014
9 Proofreading Steps Every Job Seeker Should Follow     7/24/2014
Questions To Never Ask At A Job Interview     7/24/2014
5 Mistakes That Make Your Emails Unprofessional     7/24/2014
Job Seekers: No, The Thank You Email Is Not Dead     7/24/2014
5 Most Promising Biotech Jobs By 2022     7/10/2014
6 Smart Solutions For Customizing Your Resume     7/10/2014
7 Worst Things About Job Interviews     7/10/2014
5 Tips For Standing Out At A New Job (And Fit In Too)     7/10/2014
7 Reasons Your Coworkers Don’t Trust You     7/10/2014
Surprising Things You Didn't Know You Could Negotiate     7/10/2014
Revealed: The Biggest Fears For The Newest Job Seekers     6/26/2014
3 Steps To Enhancing Your Resume In Under 20 Minutes     6/26/2014

Other News Sources
Editorial Corner
Editorial Inquiries & Guest Submissions
Rosemary Do

Press Release Submissions
Post your news